A comparative study of clinical characteristics, work‐up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore
Identifieur interne : 000943 ( Istex/Corpus ); précédent : 000942; suivant : 000944A comparative study of clinical characteristics, work‐up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore
Auteurs : Gil Yosipovitch ; Audrey Tan ; Katherine Losicco ; Catherine G. Manabat ; Ajith Kannagra ; Christie Carroll ; Yiong Huak Chan ; Patricia Ng ; Joseph JorizzoSource :
- International Journal of Dermatology [ 0011-9059 ] ; 2013-07.
English descriptors
- Teeft :
- Acad, Acad dermatol, Amyopathic, Amyopathic dermatomyositis, Arch dermatol, Bothersome symptoms, Carcinoma, Caucasian, Chinese patients, Clinical characteristics, Comparative study, Corticosteroid, Cutaneous, Cutaneous dermatomyositis, Cutaneous manifestations, Dermatol, Dermatology, Dermatology yosipovitch, Dermatomyositis, Eruption, Fitzpatrick skin type, Heliotrope eruption, Higher prevalence, International journal, International society, Interstitial lung disease, Malignancy, Muscle weakness, Nasopharyngeal, Nasopharyngeal carcinoma, Oral corticosteroids, Relative risk, Retrospective study, Singapore, Singapore group, Singapore patients, Singaporean, Singaporean patients, Skin eruption, Tacrolimus, Tertiary, Tertiary skin centers, Western countries, Yosipovitch.
Abstract
Background To date, no study has compared the clinical characteristics, malignancy associations, and treatment of dermatomyositis in predominantly Caucasian vs. Asian populations. Materials and methods This prospective study was conducted to compare clinical characteristics of dermatomyositis, its relationship to malignancy, and treatment between two tertiary medical centers in the USA and Singapore. A total of 19 newly‐diagnosed patients in the USA and 15 patients in Singapore were enrolled. Dermatomyositis or amyopathic dermatomyositis were diagnosed based on clinical assessment, skin and muscle biopsies, and muscle testing. Results Ninety‐five percent of patients in the USA group were of Caucasian descent, while 93% of patients in the Singapore group were of Chinese descent. Both groups were predominantly female. Pruritus was the most common initial symptom reported in both groups, while periungual erythema and Gottron’s papules were the most common skin presentations. Heliotrope eruption was more common in the Singapore group, occurring in 80% of patients vs. 32% of patients in the USA group (P = 0.007). Three patients in the Singapore group developed a malignancy, with two of these patients having nasopharyngeal carcinoma. None of the USA patients developed malignancies in a follow‐ up period of 2–5 years. Immunosuppressive steroid sparing therapy with hydroxychloroquine was more frequently used in Singapore, while topical tacrolimus was more frequently used in the USA. Conclusion The clinical presentations of dermatomyositis vary among different ethnic populations. Chinese patients with dermatomyositis have a significant risk for nasopharyngeal carcinoma.
Url:
DOI: 10.1111/j.1365-4632.2011.05449.x
Links to Exploration step
ISTEX:B87089D31CCF6EEDCE252176750CAF1DC4B3B16ALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A comparative study of clinical characteristics, work‐up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore</title><author><name sortKey="Yosipovitch, Gil" sort="Yosipovitch, Gil" uniqKey="Yosipovitch G" first="Gil" last="Yosipovitch">Gil Yosipovitch</name><affiliation><mods:affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</mods:affiliation></affiliation></author><author><name sortKey="Tan, Audrey" sort="Tan, Audrey" uniqKey="Tan A" first="Audrey" last="Tan">Audrey Tan</name><affiliation><mods:affiliation>Department of Dermatology, National Skin Center, Singapore</mods:affiliation></affiliation></author><author><name sortKey="Losicco, Katherine" sort="Losicco, Katherine" uniqKey="Losicco K" first="Katherine" last="Losicco">Katherine Losicco</name><affiliation><mods:affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</mods:affiliation></affiliation></author><author><name sortKey="Manabat, Catherine G" sort="Manabat, Catherine G" uniqKey="Manabat C" first="Catherine G" last="Manabat">Catherine G. Manabat</name><affiliation><mods:affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</mods:affiliation></affiliation></author><author><name sortKey="Kannagra, Ajith" sort="Kannagra, Ajith" uniqKey="Kannagra A" first="Ajith" last="Kannagra">Ajith Kannagra</name><affiliation><mods:affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</mods:affiliation></affiliation></author><author><name sortKey="Carroll, Christie" sort="Carroll, Christie" uniqKey="Carroll C" first="Christie" last="Carroll">Christie Carroll</name><affiliation><mods:affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</mods:affiliation></affiliation></author><author><name sortKey="Chan, Yiong Huak" sort="Chan, Yiong Huak" uniqKey="Chan Y" first="Yiong Huak" last="Chan">Yiong Huak Chan</name><affiliation><mods:affiliation>Biostatistics Unit, Faculty of Medicine, National University of Singapore, Singapore</mods:affiliation></affiliation></author><author><name sortKey="Ng, Patricia" sort="Ng, Patricia" uniqKey="Ng P" first="Patricia" last="Ng">Patricia Ng</name><affiliation><mods:affiliation>Department of Dermatology, National Skin Center, Singapore</mods:affiliation></affiliation></author><author><name sortKey="Jorizzo, Joseph" sort="Jorizzo, Joseph" uniqKey="Jorizzo J" first="Joseph" last="Jorizzo">Joseph Jorizzo</name><affiliation><mods:affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B87089D31CCF6EEDCE252176750CAF1DC4B3B16A</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1111/j.1365-4632.2011.05449.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-XJ8Z4VF4-9/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000943</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000943</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">A comparative study of clinical characteristics, work‐up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore</title><author><name sortKey="Yosipovitch, Gil" sort="Yosipovitch, Gil" uniqKey="Yosipovitch G" first="Gil" last="Yosipovitch">Gil Yosipovitch</name><affiliation><mods:affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</mods:affiliation></affiliation></author><author><name sortKey="Tan, Audrey" sort="Tan, Audrey" uniqKey="Tan A" first="Audrey" last="Tan">Audrey Tan</name><affiliation><mods:affiliation>Department of Dermatology, National Skin Center, Singapore</mods:affiliation></affiliation></author><author><name sortKey="Losicco, Katherine" sort="Losicco, Katherine" uniqKey="Losicco K" first="Katherine" last="Losicco">Katherine Losicco</name><affiliation><mods:affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</mods:affiliation></affiliation></author><author><name sortKey="Manabat, Catherine G" sort="Manabat, Catherine G" uniqKey="Manabat C" first="Catherine G" last="Manabat">Catherine G. Manabat</name><affiliation><mods:affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</mods:affiliation></affiliation></author><author><name sortKey="Kannagra, Ajith" sort="Kannagra, Ajith" uniqKey="Kannagra A" first="Ajith" last="Kannagra">Ajith Kannagra</name><affiliation><mods:affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</mods:affiliation></affiliation></author><author><name sortKey="Carroll, Christie" sort="Carroll, Christie" uniqKey="Carroll C" first="Christie" last="Carroll">Christie Carroll</name><affiliation><mods:affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</mods:affiliation></affiliation></author><author><name sortKey="Chan, Yiong Huak" sort="Chan, Yiong Huak" uniqKey="Chan Y" first="Yiong Huak" last="Chan">Yiong Huak Chan</name><affiliation><mods:affiliation>Biostatistics Unit, Faculty of Medicine, National University of Singapore, Singapore</mods:affiliation></affiliation></author><author><name sortKey="Ng, Patricia" sort="Ng, Patricia" uniqKey="Ng P" first="Patricia" last="Ng">Patricia Ng</name><affiliation><mods:affiliation>Department of Dermatology, National Skin Center, Singapore</mods:affiliation></affiliation></author><author><name sortKey="Jorizzo, Joseph" sort="Jorizzo, Joseph" uniqKey="Jorizzo J" first="Joseph" last="Jorizzo">Joseph Jorizzo</name><affiliation><mods:affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">International Journal of Dermatology</title><title level="j" type="alt">INTERNATIONAL JOURNAL OF DERMATOLOGY</title><idno type="ISSN">0011-9059</idno><idno type="eISSN">1365-4632</idno><imprint><biblScope unit="vol">52</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="813">813</biblScope><biblScope unit="page" to="819">819</biblScope><biblScope unit="page-count">7</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2013-07">2013-07</date></imprint><idno type="ISSN">0011-9059</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0011-9059</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acad</term><term>Acad dermatol</term><term>Amyopathic</term><term>Amyopathic dermatomyositis</term><term>Arch dermatol</term><term>Bothersome symptoms</term><term>Carcinoma</term><term>Caucasian</term><term>Chinese patients</term><term>Clinical characteristics</term><term>Comparative study</term><term>Corticosteroid</term><term>Cutaneous</term><term>Cutaneous dermatomyositis</term><term>Cutaneous manifestations</term><term>Dermatol</term><term>Dermatology</term><term>Dermatology yosipovitch</term><term>Dermatomyositis</term><term>Eruption</term><term>Fitzpatrick skin type</term><term>Heliotrope eruption</term><term>Higher prevalence</term><term>International journal</term><term>International society</term><term>Interstitial lung disease</term><term>Malignancy</term><term>Muscle weakness</term><term>Nasopharyngeal</term><term>Nasopharyngeal carcinoma</term><term>Oral corticosteroids</term><term>Relative risk</term><term>Retrospective study</term><term>Singapore</term><term>Singapore group</term><term>Singapore patients</term><term>Singaporean</term><term>Singaporean patients</term><term>Skin eruption</term><term>Tacrolimus</term><term>Tertiary</term><term>Tertiary skin centers</term><term>Western countries</term><term>Yosipovitch</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background To date, no study has compared the clinical characteristics, malignancy associations, and treatment of dermatomyositis in predominantly Caucasian vs. Asian populations. Materials and methods This prospective study was conducted to compare clinical characteristics of dermatomyositis, its relationship to malignancy, and treatment between two tertiary medical centers in the USA and Singapore. A total of 19 newly‐diagnosed patients in the USA and 15 patients in Singapore were enrolled. Dermatomyositis or amyopathic dermatomyositis were diagnosed based on clinical assessment, skin and muscle biopsies, and muscle testing. Results Ninety‐five percent of patients in the USA group were of Caucasian descent, while 93% of patients in the Singapore group were of Chinese descent. Both groups were predominantly female. Pruritus was the most common initial symptom reported in both groups, while periungual erythema and Gottron’s papules were the most common skin presentations. Heliotrope eruption was more common in the Singapore group, occurring in 80% of patients vs. 32% of patients in the USA group (P = 0.007). Three patients in the Singapore group developed a malignancy, with two of these patients having nasopharyngeal carcinoma. None of the USA patients developed malignancies in a follow‐ up period of 2–5 years. Immunosuppressive steroid sparing therapy with hydroxychloroquine was more frequently used in Singapore, while topical tacrolimus was more frequently used in the USA. Conclusion The clinical presentations of dermatomyositis vary among different ethnic populations. Chinese patients with dermatomyositis have a significant risk for nasopharyngeal carcinoma.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>dermatomyositis</json:string><json:string>singapore</json:string><json:string>dermatology</json:string><json:string>amyopathic</json:string><json:string>dermatol</json:string><json:string>singapore group</json:string><json:string>amyopathic dermatomyositis</json:string><json:string>cutaneous</json:string><json:string>nasopharyngeal</json:string><json:string>singaporean</json:string><json:string>nasopharyngeal carcinoma</json:string><json:string>malignancy</json:string><json:string>acad</json:string><json:string>corticosteroid</json:string><json:string>carcinoma</json:string><json:string>international society</json:string><json:string>tertiary skin centers</json:string><json:string>comparative study</json:string><json:string>tacrolimus</json:string><json:string>yosipovitch</json:string><json:string>clinical characteristics</json:string><json:string>interstitial lung disease</json:string><json:string>acad dermatol</json:string><json:string>tertiary</json:string><json:string>arch dermatol</json:string><json:string>international journal</json:string><json:string>singaporean patients</json:string><json:string>oral corticosteroids</json:string><json:string>chinese patients</json:string><json:string>fitzpatrick skin type</json:string><json:string>muscle weakness</json:string><json:string>singapore patients</json:string><json:string>retrospective study</json:string><json:string>skin eruption</json:string><json:string>caucasian</json:string><json:string>cutaneous manifestations</json:string><json:string>dermatology yosipovitch</json:string><json:string>relative risk</json:string><json:string>western countries</json:string><json:string>bothersome symptoms</json:string><json:string>heliotrope eruption</json:string><json:string>cutaneous dermatomyositis</json:string><json:string>higher prevalence</json:string><json:string>eruption</json:string></teeft></keywords><author><json:item><name>Gil Yosipovitch MD</name><affiliations><json:string>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</json:string></affiliations></json:item><json:item><name>Audrey Tan MBBS</name><affiliations><json:string>Department of Dermatology, National Skin Center, Singapore</json:string></affiliations></json:item><json:item><name>Katherine LoSicco MD</name><affiliations><json:string>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</json:string></affiliations></json:item><json:item><name>Catherine G Manabat MD</name><affiliations><json:string>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</json:string></affiliations></json:item><json:item><name>Ajith Kannagra MD</name><affiliations><json:string>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</json:string></affiliations></json:item><json:item><name>Christie Carroll MD</name><affiliations><json:string>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</json:string></affiliations></json:item><json:item><name>Yiong Huak Chan PhD</name><affiliations><json:string>Biostatistics Unit, Faculty of Medicine, National University of Singapore, Singapore</json:string></affiliations></json:item><json:item><name>Patricia Ng MBBS</name><affiliations><json:string>Department of Dermatology, National Skin Center, Singapore</json:string></affiliations></json:item><json:item><name>Joseph Jorizzo MD</name><affiliations><json:string>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</json:string></affiliations></json:item></author><articleId><json:string>IJD5449</json:string></articleId><arkIstex>ark:/67375/WNG-XJ8Z4VF4-9</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>shortCommunication</json:string></originalGenre><abstract>Background To date, no study has compared the clinical characteristics, malignancy associations, and treatment of dermatomyositis in predominantly Caucasian vs. Asian populations. Materials and methods This prospective study was conducted to compare clinical characteristics of dermatomyositis, its relationship to malignancy, and treatment between two tertiary medical centers in the USA and Singapore. A total of 19 newly‐diagnosed patients in the USA and 15 patients in Singapore were enrolled. Dermatomyositis or amyopathic dermatomyositis were diagnosed based on clinical assessment, skin and muscle biopsies, and muscle testing. Results Ninety‐five percent of patients in the USA group were of Caucasian descent, while 93% of patients in the Singapore group were of Chinese descent. Both groups were predominantly female. Pruritus was the most common initial symptom reported in both groups, while periungual erythema and Gottron’s papules were the most common skin presentations. Heliotrope eruption was more common in the Singapore group, occurring in 80% of patients vs. 32% of patients in the USA group (P = 0.007). Three patients in the Singapore group developed a malignancy, with two of these patients having nasopharyngeal carcinoma. None of the USA patients developed malignancies in a follow‐ up period of 2–5 years. Immunosuppressive steroid sparing therapy with hydroxychloroquine was more frequently used in Singapore, while topical tacrolimus was more frequently used in the USA. Conclusion The clinical presentations of dermatomyositis vary among different ethnic populations. Chinese patients with dermatomyositis have a significant risk for nasopharyngeal carcinoma.</abstract><qualityIndicators><score>8.652</score><pdfWordCount>3820</pdfWordCount><pdfCharCount>26398</pdfCharCount><pdfVersion>1.7</pdfVersion><pdfPageCount>7</pdfPageCount><pdfPageSize>595.276 x 782.362 pts</pdfPageSize><pdfWordsPerPage>546</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>236</abstractWordCount><abstractCharCount>1693</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>A comparative study of clinical characteristics, work‐up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore</title><pmid><json:string>22835263</json:string></pmid><genre><json:string>brief-communication</json:string></genre><host><title>International Journal of Dermatology</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1365-4632</json:string></doi><issn><json:string>0011-9059</json:string></issn><eissn><json:string>1365-4632</json:string></eissn><publisherId><json:string>IJD</json:string></publisherId><volume>52</volume><issue>7</issue><pages><first>813</first><last>819</last><total>7</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Report</value></json:item><json:item><value>Report</value></json:item></subject></host><namedEntities><unitex><date><json:string>1000</json:string><json:string>2013</json:string></date><geogName></geogName><orgName><json:string>NSC, Singapore</json:string><json:string>USA and Singapore Report Table</json:string><json:string>MD Department of Dermatology Wake Forest University Medical Center Boulevard Winston Salem NC</json:string><json:string>National Skin Centre</json:string><json:string>National University of Singapore, Singapore Abstract Background To</json:string><json:string>Singapore and USA</json:string><json:string>Department of Dermatology, National Skin Center, Singapore</json:string><json:string>Wake Forest University</json:string><json:string>USA International Journal</json:string><json:string>Sex Female Male Ethnicity Caucasian African–American Chinese Thai Classic</json:string><json:string>Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA</json:string><json:string>China and Southeast Asia</json:string><json:string>USA and Singapore Table</json:string><json:string>NSC</json:string><json:string>The International Society</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Departments</json:string><json:string>Hong Kong</json:string><json:string>Patricia Ng</json:string><json:string>Correspondence</json:string><json:string>Patients</json:string><json:string>Catherine G. Manabat</json:string><json:string>Katherine LoSicco</json:string><json:string>Gil Yosipovitch</json:string><json:string>Joseph Jorizzo</json:string><json:string>Christie Carroll</json:string></persName><placeName><json:string>IL</json:string><json:string>Singapore</json:string><json:string>China</json:string><json:string>USA</json:string><json:string>Chicago</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>Yosipovitch et al.</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-XJ8Z4VF4-9</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - dermatology</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - dermatology & venereal diseases</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Dermatology</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2013</publicationDate><copyrightDate>2013</copyrightDate><doi><json:string>10.1111/j.1365-4632.2011.05449.x</json:string></doi><id>B87089D31CCF6EEDCE252176750CAF1DC4B3B16A</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XJ8Z4VF4-9/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XJ8Z4VF4-9/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-XJ8Z4VF4-9/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">A comparative study of clinical characteristics, work‐up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore</title><title level="a" type="short">A comparative study between two tertiary skin centers in the USA and Singapore</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><availability><licence>© 2012 The International Society of Dermatology</licence></availability><date type="published" when="2013-07"></date></publicationStmt><notesStmt><note type="content-type" subtype="brief-communication" source="shortCommunication" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-S9SX2MFS-0">brief-communication</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="brief-communication"><analytic><title level="a" type="main">A comparative study of clinical characteristics, work‐up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore</title><title level="a" type="short">A comparative study between two tertiary skin centers in the USA and Singapore</title><author xml:id="author-0000"><persName><forename type="first">Gil</forename><surname>Yosipovitch</surname><roleName type="degree">MD</roleName></persName><affiliation><orgName type="department">Department of Dermatology</orgName><orgName type="institution">Wake Forest University School of Medicine</orgName><address><addrLine>Winston‐Salem</addrLine><addrLine>NC, USA</addrLine><country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">Audrey</forename><surname>Tan</surname><roleName type="degree">MBBS</roleName></persName><affiliation><orgName type="department">Department of Dermatology</orgName><orgName type="institution">National Skin Center</orgName><address><addrLine>Singapore</addrLine><country key="SG" xml:lang="en">SINGAPORE</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">Katherine</forename><surname>LoSicco</surname><roleName type="degree">MD</roleName></persName><affiliation><orgName type="department">Department of Dermatology</orgName><orgName type="institution">Wake Forest University School of Medicine</orgName><address><addrLine>Winston‐Salem</addrLine><addrLine>NC, USA</addrLine><country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">Catherine G</forename><surname>Manabat</surname><roleName type="degree">MD</roleName></persName><affiliation><orgName type="department">Department of Dermatology</orgName><orgName type="institution">Wake Forest University School of Medicine</orgName><address><addrLine>Winston‐Salem</addrLine><addrLine>NC, USA</addrLine><country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0004"><persName><forename type="first">Ajith</forename><surname>Kannagra</surname><roleName type="degree">MD</roleName></persName><affiliation><orgName type="department">Department of Dermatology</orgName><orgName type="institution">Wake Forest University School of Medicine</orgName><address><addrLine>Winston‐Salem</addrLine><addrLine>NC, USA</addrLine><country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0005"><persName><forename type="first">Christie</forename><surname>Carroll</surname><roleName type="degree">MD</roleName></persName><affiliation><orgName type="department">Department of Dermatology</orgName><orgName type="institution">Wake Forest University School of Medicine</orgName><address><addrLine>Winston‐Salem</addrLine><addrLine>NC, USA</addrLine><country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0006"><persName><forename type="first">Yiong Huak</forename><surname>Chan</surname><roleName type="degree">PhD</roleName></persName><affiliation><orgName type="laboratory">Biostatistics Unit</orgName><orgName type="department">Faculty of Medicine</orgName><orgName type="institution">National University of Singapore</orgName><address><addrLine>Singapore</addrLine><country key="SG" xml:lang="en">SINGAPORE</country></address></affiliation></author><author xml:id="author-0007"><persName><forename type="first">Patricia</forename><surname>Ng</surname><roleName type="degree">MBBS</roleName></persName><affiliation><orgName type="department">Department of Dermatology</orgName><orgName type="institution">National Skin Center</orgName><address><addrLine>Singapore</addrLine><country key="SG" xml:lang="en">SINGAPORE</country></address></affiliation></author><author xml:id="author-0008"><persName><forename type="first">Joseph</forename><surname>Jorizzo</surname><roleName type="degree">MD</roleName></persName><affiliation><orgName type="department">Department of Dermatology</orgName><orgName type="institution">Wake Forest University School of Medicine</orgName><address><addrLine>Winston‐Salem</addrLine><addrLine>NC, USA</addrLine><country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><idno type="istex">B87089D31CCF6EEDCE252176750CAF1DC4B3B16A</idno><idno type="ark">ark:/67375/WNG-XJ8Z4VF4-9</idno><idno type="DOI">10.1111/j.1365-4632.2011.05449.x</idno><idno type="unit">IJD5449</idno><idno type="toTypesetVersion">file:IJD.IJD5449.pdf</idno></analytic><monogr><title level="j" type="main">International Journal of Dermatology</title><title level="j" type="alt">INTERNATIONAL JOURNAL OF DERMATOLOGY</title><idno type="pISSN">0011-9059</idno><idno type="eISSN">1365-4632</idno><idno type="book-DOI">10.1111/(ISSN)1365-4632</idno><idno type="book-part-DOI">10.1111/ijd.2013.52.issue-7</idno><idno type="product">IJD</idno><idno type="publisherDivision">ST</idno><imprint><biblScope unit="vol">52</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="813">813</biblScope><biblScope unit="page" to="819">819</biblScope><biblScope unit="page-count">7</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2013-07"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract xml:lang="en" style="main"><head>Abstract</head><p><hi rend="bold">Background </hi> To date, no study has compared the clinical characteristics, malignancy associations, and treatment of dermatomyositis in predominantly Caucasian vs. Asian populations.</p><p><hi rend="bold">Materials and methods </hi> This prospective study was conducted to compare clinical characteristics of dermatomyositis, its relationship to malignancy, and treatment between two tertiary medical centers in the USA and Singapore. A total of 19 newly‐diagnosed patients in the USA and 15 patients in Singapore were enrolled. Dermatomyositis or amyopathic dermatomyositis were diagnosed based on clinical assessment, skin and muscle biopsies, and muscle testing.</p><p><hi rend="bold">Results </hi> Ninety‐five percent of patients in the USA group were of Caucasian descent, while 93% of patients in the Singapore group were of Chinese descent. Both groups were predominantly female. Pruritus was the most common initial symptom reported in both groups, while periungual erythema and Gottron’s papules were the most common skin presentations. Heliotrope eruption was more common in the Singapore group, occurring in 80% of patients vs. 32% of patients in the USA group (<hi rend="italic">P</hi> = 0.007). Three patients in the Singapore group developed a malignancy, with two of these patients having nasopharyngeal carcinoma. None of the USA patients developed malignancies in a follow‐ up period of 2–5 years. Immunosuppressive steroid sparing therapy with hydroxychloroquine was more frequently used in Singapore, while topical tacrolimus was more frequently used in the USA.</p><p><hi rend="bold">Conclusion </hi> The clinical presentations of dermatomyositis vary among different ethnic populations. Chinese patients with dermatomyositis have a significant risk for nasopharyngeal carcinoma.</p></abstract><textClass><keywords rend="tocHeading1"><term>Report</term></keywords><keywords rend="articleCategory"><term>Report</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XJ8Z4VF4-9/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1365-4632</doi><issn type="print">0011-9059</issn><issn type="electronic">1365-4632</issn><idGroup><id type="product" value="IJD"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="INTERNATIONAL JOURNAL OF DERMATOLOGY">International Journal of Dermatology</title></titleGroup></publicationMeta><publicationMeta level="part" position="07107"><doi origin="wiley">10.1111/ijd.2013.52.issue-7</doi><numberingGroup><numbering type="journalVolume" number="52">52</numbering><numbering type="journalIssue" number="7">7</numbering></numberingGroup><coverDate startDate="2013-07">July 2013</coverDate></publicationMeta><publicationMeta level="unit" type="shortCommunication" position="8" status="forIssue"><doi origin="wiley">10.1111/j.1365-4632.2011.05449.x</doi><idGroup><id type="unit" value="IJD5449"></id></idGroup><countGroup><count type="pageTotal" number="7"></count></countGroup><titleGroup><title type="tocHeading1">Report</title><title type="articleCategory">Report</title></titleGroup><copyright>© 2012 The International Society of Dermatology</copyright><eventGroup><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:3.2.2 mode:FullText" date="2013-06-06"></event><event agent="SPS" date="2013-06-06" type="xmlCorrected"></event><event type="publishedOnlineEarlyUnpaginated" date="2012-07-27"></event><event type="firstOnline" date="2012-07-27"></event><event type="publishedOnlineFinalForm" date="2013-06-23"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-13"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.6.4 mode:FullText" date="2015-10-02"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="813">813</numbering><numbering type="pageLast" number="819">819</numbering></numberingGroup><correspondenceTo>Gil Yosipovitch, <sc>md</sc>
Department of Dermatology
Wake Forest University
Medical Center Boulevard
Winston Salem
NC 27157‐0001
USA
E‐mail: <email>gyosipov@wfubmc.edu</email></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:IJD.IJD5449.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="3"></count></countGroup><titleGroup><title type="main">A comparative study of clinical characteristics, work‐up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore</title><title type="shortAuthors"><i>Yosipovitch et al.</i></title><title type="short">A comparative study between two tertiary skin centers in the USA and Singapore</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1"><personName><givenNames>Gil</givenNames><familyName>Yosipovitch</familyName><degrees>MD</degrees></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a2"><personName><givenNames>Audrey</givenNames><familyName>Tan</familyName><degrees>MBBS</degrees></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#a1"><personName><givenNames>Katherine</givenNames><familyName>LoSicco</familyName><degrees>MD</degrees></personName></creator><creator creatorRole="author" xml:id="cr4" affiliationRef="#a1"><personName><givenNames>Catherine G</givenNames><familyName>Manabat</familyName><degrees>MD</degrees></personName></creator><creator creatorRole="author" xml:id="cr5" affiliationRef="#a1"><personName><givenNames>Ajith</givenNames><familyName>Kannagra</familyName><degrees>MD</degrees></personName></creator><creator creatorRole="author" xml:id="cr6" affiliationRef="#a1"><personName><givenNames>Christie</givenNames><familyName>Carroll</familyName><degrees>MD</degrees></personName></creator><creator creatorRole="author" xml:id="cr7" affiliationRef="#a3"><personName><givenNames>Yiong Huak</givenNames><familyName>Chan</familyName><degrees>PhD</degrees></personName></creator><creator creatorRole="author" xml:id="cr8" affiliationRef="#a2"><personName><givenNames>Patricia</givenNames><familyName>Ng</familyName><degrees>MBBS</degrees></personName></creator><creator creatorRole="author" xml:id="cr9" affiliationRef="#a1"><personName><givenNames>Joseph</givenNames><familyName>Jorizzo</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="US"><unparsedAffiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</unparsedAffiliation></affiliation><affiliation xml:id="a2" countryCode="SG"><unparsedAffiliation>Department of Dermatology, National Skin Center, Singapore</unparsedAffiliation></affiliation><affiliation xml:id="a3" countryCode="SG"><unparsedAffiliation>Biostatistics Unit, Faculty of Medicine, National University of Singapore, Singapore</unparsedAffiliation></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p><b>Background </b> To date, no study has compared the clinical characteristics, malignancy associations, and treatment of dermatomyositis in predominantly Caucasian vs. Asian populations.</p><p><b>Materials and methods </b> This prospective study was conducted to compare clinical characteristics of dermatomyositis, its relationship to malignancy, and treatment between two tertiary medical centers in the USA and Singapore. A total of 19 newly‐diagnosed patients in the USA and 15 patients in Singapore were enrolled. Dermatomyositis or amyopathic dermatomyositis were diagnosed based on clinical assessment, skin and muscle biopsies, and muscle testing.</p><p><b>Results </b> Ninety‐five percent of patients in the USA group were of Caucasian descent, while 93% of patients in the Singapore group were of Chinese descent. Both groups were predominantly female. Pruritus was the most common initial symptom reported in both groups, while periungual erythema and Gottron’s papules were the most common skin presentations. Heliotrope eruption was more common in the Singapore group, occurring in 80% of patients vs. 32% of patients in the USA group (<i>P</i> = 0.007). Three patients in the Singapore group developed a malignancy, with two of these patients having nasopharyngeal carcinoma. None of the USA patients developed malignancies in a follow‐ up period of 2–5 years. Immunosuppressive steroid sparing therapy with hydroxychloroquine was more frequently used in Singapore, while topical tacrolimus was more frequently used in the USA.</p><p><b>Conclusion </b> The clinical presentations of dermatomyositis vary among different ethnic populations. Chinese patients with dermatomyositis have a significant risk for nasopharyngeal carcinoma.</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p>Funding sources: None.</p></note><note xml:id="fn2"><p>Conflict of interest disclosure: None declared.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>A comparative study of clinical characteristics, work‐up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>A comparative study between two tertiary skin centers in the USA and Singapore</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>A comparative study of clinical characteristics, work‐up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore</title></titleInfo><name type="personal"><namePart type="given">Gil</namePart><namePart type="family">Yosipovitch</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Audrey</namePart><namePart type="family">Tan</namePart><namePart type="termsOfAddress">MBBS</namePart><affiliation>Department of Dermatology, National Skin Center, Singapore</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Katherine</namePart><namePart type="family">LoSicco</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Catherine G</namePart><namePart type="family">Manabat</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Ajith</namePart><namePart type="family">Kannagra</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Christie</namePart><namePart type="family">Carroll</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Yiong Huak</namePart><namePart type="family">Chan</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Biostatistics Unit, Faculty of Medicine, National University of Singapore, Singapore</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Patricia</namePart><namePart type="family">Ng</namePart><namePart type="termsOfAddress">MBBS</namePart><affiliation>Department of Dermatology, National Skin Center, Singapore</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Joseph</namePart><namePart type="family">Jorizzo</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Dermatology, Wake Forest University School of Medicine, Winston‐Salem, NC, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="brief-communication" displayLabel="shortCommunication" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-S9SX2MFS-0">brief-communication</genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">2013-07</dateIssued><copyrightDate encoding="w3cdtf">2013</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><extent unit="figures">0</extent><extent unit="tables">3</extent></physicalDescription><abstract lang="en">Background To date, no study has compared the clinical characteristics, malignancy associations, and treatment of dermatomyositis in predominantly Caucasian vs. Asian populations. Materials and methods This prospective study was conducted to compare clinical characteristics of dermatomyositis, its relationship to malignancy, and treatment between two tertiary medical centers in the USA and Singapore. A total of 19 newly‐diagnosed patients in the USA and 15 patients in Singapore were enrolled. Dermatomyositis or amyopathic dermatomyositis were diagnosed based on clinical assessment, skin and muscle biopsies, and muscle testing. Results Ninety‐five percent of patients in the USA group were of Caucasian descent, while 93% of patients in the Singapore group were of Chinese descent. Both groups were predominantly female. Pruritus was the most common initial symptom reported in both groups, while periungual erythema and Gottron’s papules were the most common skin presentations. Heliotrope eruption was more common in the Singapore group, occurring in 80% of patients vs. 32% of patients in the USA group (P = 0.007). Three patients in the Singapore group developed a malignancy, with two of these patients having nasopharyngeal carcinoma. None of the USA patients developed malignancies in a follow‐ up period of 2–5 years. Immunosuppressive steroid sparing therapy with hydroxychloroquine was more frequently used in Singapore, while topical tacrolimus was more frequently used in the USA. Conclusion The clinical presentations of dermatomyositis vary among different ethnic populations. Chinese patients with dermatomyositis have a significant risk for nasopharyngeal carcinoma.</abstract><relatedItem type="host"><titleInfo><title>International Journal of Dermatology</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>Report</topic><topic>Report</topic></subject><identifier type="ISSN">0011-9059</identifier><identifier type="eISSN">1365-4632</identifier><identifier type="DOI">10.1111/(ISSN)1365-4632</identifier><identifier type="PublisherID">IJD</identifier><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><detail type="issue"><caption>no.</caption><number>7</number></detail><extent unit="pages"><start>813</start><end>819</end><total>7</total></extent></part></relatedItem><relatedItem type="references" displayLabel="cit1"><titleInfo><title>Incidence of polymyositis‐dermatomyositis: a 20‐year study of hospital diagnosed cases in Allegheny County, PA 1963–1982</title></titleInfo><name type="personal"><namePart type="given">CV</namePart><namePart type="family">Oddis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CG</namePart><namePart type="family">Conte</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">VD</namePart><namePart type="family">Steen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Oddis CV, Conte CG, Steen VD, et al. Incidence of polymyositis‐dermatomyositis: a 20‐year study of hospital diagnosed cases in Allegheny County, PA 1963–1982. J Rheumatol1990; 17: 1329–1334.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>1329</start><end>1334</end></extent></part><relatedItem type="host"><titleInfo><title>J Rheumatol</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>1329</start><end>1334</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit2"><titleInfo><title>Treatment of dermatomyositis and polymyositis</title></titleInfo><name type="personal"><namePart type="given">EH</namePart><namePart type="family">Choy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DA</namePart><namePart type="family">Isenberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Choy EH, Isenberg DA. Treatment of dermatomyositis and polymyositis. Rheumatology (Oxford)2002; 41: 7–13.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>7</start><end>13</end></extent></part><relatedItem type="host"><titleInfo><title>Rheumatology (Oxford)</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>7</start><end>13</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit3"><titleInfo><title>Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients</title></titleInfo><name type="personal"><namePart type="given">ET</namePart><namePart type="family">Koh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Seow</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Ong</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Koh ET, Seow A, Ong B, et al. Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis1993; 52: 857–861.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>857</start><end>861</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Rheum Dis</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>857</start><end>861</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit4"><titleInfo><title>Dermatomyositis sine myositis: association with malignancy</title></titleInfo><name type="personal"><namePart type="given">SE</namePart><namePart type="family">Whitmore</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Watson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NB</namePart><namePart type="family">Rosenshein</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Whitmore SE, Watson R, Rosenshein NB, et al. Dermatomyositis sine myositis: association with malignancy. J Rheumatol1996; 23: 101–105.</note><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>101</start><end>105</end></extent></part><relatedItem type="host"><titleInfo><title>J Rheumatol</title></titleInfo><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>101</start><end>105</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit5"><titleInfo><title>Dermatomyositis: a dermatology‐based case series</title></titleInfo><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Dawkins</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Jorizzo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FO</namePart><namePart type="family">Walker</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dawkins MA, Jorizzo JL, Walker FO, et al. Dermatomyositis: a dermatology‐based case series. J Am Acad Dermatol1998; 38: 397–404.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>397</start><end>404</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>397</start><end>404</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit6"><titleInfo><title>Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature</title></titleInfo><name type="personal"><namePart type="given">RL</namePart><namePart type="family">Euwer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RD</namePart><namePart type="family">Sontheimer</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol1991; 1: 959–966.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>959</start><end>966</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>959</start><end>966</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit7"><titleInfo><title>Dermatomyositis in six patients without initial muscle involvement</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Krain</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Krain L. Dermatomyositis in six patients without initial muscle involvement. Arch Dermatol1975; 111: 241–245.</note><part><date>1975</date><detail type="volume"><caption>vol.</caption><number>111</number></detail><extent unit="pages"><start>241</start><end>245</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Dermatol</title></titleInfo><part><date>1975</date><detail type="volume"><caption>vol.</caption><number>111</number></detail><extent unit="pages"><start>241</start><end>245</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit8"><titleInfo><title>A systematic review of adult‐onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Gerami</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Schope</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">McDonald</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gerami P, Schope JM, McDonald L, et al. A systematic review of adult‐onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol2006; 54: 597–613.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>54</number></detail><extent unit="pages"><start>597</start><end>613</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>54</number></detail><extent unit="pages"><start>597</start><end>613</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit9"><titleInfo><title>Interstitial lung disease associated with amyopathic dermatomyositis: review of 18 cases</title></titleInfo><name type="personal"><namePart type="given">G</namePart><namePart type="family">Ideura</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Hanaoka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Koizumi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ideura G, Hanaoka M, Koizumi T, et al. Interstitial lung disease associated with amyopathic dermatomyositis: review of 18 cases. Respir Med2007; 101: 1406–1411.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>101</number></detail><extent unit="pages"><start>1406</start><end>1411</end></extent></part><relatedItem type="host"><titleInfo><title>Respir Med</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>101</number></detail><extent unit="pages"><start>1406</start><end>1411</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit10"><titleInfo><title>Pulmonary damage during polymyositis and dermatomyositis: interstitial lung disease</title></titleInfo><name type="personal"><namePart type="given">I</namePart><namePart type="family">Marie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Dominique</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Marie I, Dominique S. Pulmonary damage during polymyositis and dermatomyositis: interstitial lung disease. Presse Med2006; 2: 683–695.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>683</start><end>695</end></extent></part><relatedItem type="host"><titleInfo><title>Presse Med</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>683</start><end>695</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit11"><titleInfo><title>Interstitial lung disease in polymyositis and dermatomyositis</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Songcharoen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SF</namePart><namePart type="family">Raju</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JB</namePart><namePart type="family">Pennebaker</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Songcharoen S, Raju SF, Pennebaker JB. Interstitial lung disease in polymyositis and dermatomyositis. J Rheumatol1980; 7: 353–360.</note><part><date>1980</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>353</start><end>360</end></extent></part><relatedItem type="host"><titleInfo><title>J Rheumatol</title></titleInfo><part><date>1980</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>353</start><end>360</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit12"><titleInfo><title>Risk of cancer in patients with dermatomyositis or polymyositis. A population‐based study</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Sigurgeirsson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Lindelöf</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O</namePart><namePart type="family">Edhag</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sigurgeirsson B, Lindelöf B, Edhag O, et al. Risk of cancer in patients with dermatomyositis or polymyositis. A population‐based study. N Engl J Med1992; 326: 363–367.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>326</number></detail><extent unit="pages"><start>363</start><end>367</end></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>326</number></detail><extent unit="pages"><start>363</start><end>367</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit13"><titleInfo><title>Dermatomyositis</title></titleInfo><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Callen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RL</namePart><namePart type="family">Wortmann</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Callen JP, Wortmann RL. Dermatomyositis. Clin Dermatol2006; 24: 363–373.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>363</start><end>373</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Dermatol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>363</start><end>373</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit14"><titleInfo><title>The enigmatic epidemiology of nasopharyngeal carcinoma</title></titleInfo><name type="personal"><namePart type="given">ET</namePart><namePart type="family">Chang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HO</namePart><namePart type="family">Adami</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev2006; 15: 1765–1777.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>1765</start><end>1777</end></extent></part><relatedItem type="host"><titleInfo><title>Cancer Epidemiol Biomarkers Prev</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>1765</start><end>1777</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit15"><titleInfo><title>Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3‐year retrospective review of their clinical characteristics and association with malignancy</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Ang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MW</namePart><namePart type="family">Sugeng</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SH</namePart><namePart type="family">Chua</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ang P, Sugeng MW, Chua SH. Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3‐year retrospective review of their clinical characteristics and association with malignancy. Ann Acad Med Singapore2000; 29: 219–223.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>219</start><end>223</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Acad Med Singapore</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>219</start><end>223</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit16"><titleInfo><title>Dermatomyositis and cancer in Singapore</title></titleInfo><name type="personal"><namePart type="given">HL</namePart><namePart type="family">Chan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chan HL. Dermatomyositis and cancer in Singapore. Int J Dermatol1985; 24: 447–450.</note><part><date>1985</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>447</start><end>450</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Dermatol</title></titleInfo><part><date>1985</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>447</start><end>450</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit17"><titleInfo><title>Dermatomyositis in a skin clinic</title></titleInfo><name type="personal"><namePart type="given">CL</namePart><namePart type="family">Goh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">VS</namePart><namePart type="family">Rajan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Goh CL, Rajan VS. Dermatomyositis in a skin clinic. Ann Acad Med Singapore1983; 12: 6–12.</note><part><date>1983</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>6</start><end>12</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Acad Med Singapore</title></titleInfo><part><date>1983</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>6</start><end>12</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit18"><titleInfo><title>Malignancy in adult dermatomyositis</title></titleInfo><name type="personal"><namePart type="given">YH</namePart><namePart type="family">Leow</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CL</namePart><namePart type="family">Goh</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Leow YH, Goh CL. Malignancy in adult dermatomyositis. Int J Dermatol1997; 36: 904–907.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>904</start><end>907</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Dermatol</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>904</start><end>907</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit19"><titleInfo><title>Amyopathic dermatomyositis in Hong Kong – association with nasopharyngeal carcinoma</title></titleInfo><name type="personal"><namePart type="given">WK</namePart><namePart type="family">Fung</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HL</namePart><namePart type="family">Chan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WM</namePart><namePart type="family">Lam</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fung WK, Chan HL, Lam WM. Amyopathic dermatomyositis in Hong Kong – association with nasopharyngeal carcinoma. Int J Dermatol1998; 37: 659–663.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>659</start><end>663</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Dermatol</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>659</start><end>663</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit20"><titleInfo><title>MR imaging in amyopathic dermatomyositis</title></titleInfo><name type="personal"><namePart type="given">WW</namePart><namePart type="family">Lam</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Chan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">YL</namePart><namePart type="family">Chan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lam WW, Chan H, Chan YL, et al. MR imaging in amyopathic dermatomyositis. Acta Radiol1999; 40: 69–72.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>69</start><end>72</end></extent></part><relatedItem type="host"><titleInfo><title>Acta Radiol</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>69</start><end>72</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit21"><titleInfo><title>Dermatomyositis and malignancy: a retrospective study of 115 cases</title></titleInfo><name type="personal"><namePart type="given">W</namePart><namePart type="family">Zhang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SP</namePart><namePart type="family">Jiang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Huang</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zhang W, Jiang SP, Huang L. Dermatomyositis and malignancy: a retrospective study of 115 cases. Eur Rev Med Pharmacol Sci2009; 13: 77–80.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>77</start><end>80</end></extent></part><relatedItem type="host"><titleInfo><title>Eur Rev Med Pharmacol Sci</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>77</start><end>80</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit22"><titleInfo><title>Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population‐based study in Olmsted County, Minnesota</title></titleInfo><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">Bendewald</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DA</namePart><namePart type="family">Wetter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X</namePart><namePart type="family">Li</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bendewald MJ, Wetter DA, Li X, et al. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population‐based study in Olmsted County, Minnesota. Arch Dermatol2010; 146: 26–30.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>146</number></detail><extent unit="pages"><start>26</start><end>30</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Dermatol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>146</number></detail><extent unit="pages"><start>26</start><end>30</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit23"><titleInfo><title>Management of cutaneous dermatomyositis: current therapeutic options</title></titleInfo><name type="personal"><namePart type="given">RD</namePart><namePart type="family">Quain</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">VP</namePart><namePart type="family">Werth</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Quain RD, Werth VP. Management of cutaneous dermatomyositis: current therapeutic options. Am J Clin Dermatol2006; 7: 341–351.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>341</start><end>351</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Clin Dermatol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>341</start><end>351</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit24"><titleInfo><title>The treatment and prognosis of dermatomyositis: an updated review</title></titleInfo><name type="personal"><namePart type="given">LJ</namePart><namePart type="family">Iorizzo III</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Jorizzo</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Iorizzo LJ III, Jorizzo JL. The treatment and prognosis of dermatomyositis: an updated review. J Am Acad Dermatol2008; 59: 99–112. Epub 2008 Apr 18.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>59</number></detail><extent unit="pages"><start>99</start><end>112</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>59</number></detail><extent unit="pages"><start>99</start><end>112</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit25"><titleInfo><title>Dermatomyositis</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Jorizzo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Carroll</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O</namePart><namePart type="family">Sangueza</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book-chapter</genre><relatedItem type="host"><titleInfo><title>Dermatology</title></titleInfo><originInfo><publisher>Mosby Elsevier</publisher></originInfo><part><date>2008</date><extent unit="pages"><start>575</start><end>582</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit26"><titleInfo><title>Polymyositis and dermatomyositis (first of two parts)</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Bohan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JB</namePart><namePart type="family">Peter</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med1975; 292: 344–347.</note><part><date>1975</date><detail type="volume"><caption>vol.</caption><number>292</number></detail><extent unit="pages"><start>344</start><end>347</end></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>1975</date><detail type="volume"><caption>vol.</caption><number>292</number></detail><extent unit="pages"><start>344</start><end>347</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit27"><titleInfo><title>Development and validation of the dermatomyositis skin severity index</title></titleInfo><name type="personal"><namePart type="given">CL</namePart><namePart type="family">Carroll</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Lang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Snively</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Carroll CL, Lang W, Snively B, et al. Development and validation of the dermatomyositis skin severity index. Br J Dermatol2008; 158: 345–350. Epub 2007 Dec.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>345</start><end>350</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>345</start><end>350</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit28"><titleInfo><title>Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center</title></titleInfo><name type="personal"><namePart type="given">RQ</namePart><namePart type="family">Klein</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V</namePart><namePart type="family">Teal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Taylor</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Klein RQ, Teal V, Taylor L, et al. Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center. J Am Acad Dermatol2007; 57: 937–943. Epub 2007 Oct 17.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>937</start><end>943</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>937</start><end>943</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit29"><titleInfo><title>Cutaneous symptoms of dermatomyositis significantly impact patients’ quality of life</title></titleInfo><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Hundley</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CL</namePart><namePart type="family">Carroll</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Lang</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hundley JL, Carroll CL, Lang W, et al. Cutaneous symptoms of dermatomyositis significantly impact patients’ quality of life. J Am Acad Dermatol2006; 54: 217–220.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>54</number></detail><extent unit="pages"><start>217</start><end>220</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>54</number></detail><extent unit="pages"><start>217</start><end>220</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit30"><titleInfo><title>Callen JP, Jorizzo JL, Bolognia JL, et al.Dermatological Signs of Internal Disease, 4th edn. Amsterdam: Elsevier, 2009: 11–19.</title></titleInfo><note type="citation/reference">Callen JP, Jorizzo JL, Bolognia JL, et al.Dermatological Signs of Internal Disease, 4th edn. Amsterdam: Elsevier, 2009: 11–19.</note><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Callen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Jorizzo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Bolognia</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>Elsevier</publisher></originInfo><part><date>2009</date><extent unit="pages"><start>11</start><end>19</end></extent></part></relatedItem><relatedItem type="references" displayLabel="cit31"><titleInfo><title>Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992–2002</title></titleInfo><name type="personal"><namePart type="given">LM</namePart><namePart type="family">Sun</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Epplein</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CI</namePart><namePart type="family">Li</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sun LM, Epplein M, Li CI, et al. Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992–2002. Am J Epidemiol2005; 162: 1174–1178. Epub 2005 Nov 9.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>162</number></detail><extent unit="pages"><start>1174</start><end>1178</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Epidemiol</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>162</number></detail><extent unit="pages"><start>1174</start><end>1178</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit32"><titleInfo><title>Interstitial lung disease in classic and skin‐predominant dermatomyositis: a retrospective study with screening recommendations</title></titleInfo><name type="personal"><namePart type="given">PA</namePart><namePart type="family">Morganroth</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ME</namePart><namePart type="family">Kreider</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Okawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Morganroth PA, Kreider ME, Okawa J, et al. Interstitial lung disease in classic and skin‐predominant dermatomyositis: a retrospective study with screening recommendations. Arch Dermatol2010; 146: 729–738. Erratum in: Arch Dermatol 2010; 146: 1197.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>146</number></detail><extent unit="pages"><start>729</start><end>738</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Dermatol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>146</number></detail><extent unit="pages"><start>729</start><end>738</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit33"><titleInfo><title>Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study</title></titleInfo><name type="personal"><namePart type="given">GC</namePart><namePart type="family">Ang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">VP</namePart><namePart type="family">Werth</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ang GC, Werth VP. Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study. Arch Dermatol2005; 141: 855–859.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>141</number></detail><extent unit="pages"><start>855</start><end>859</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Dermatol</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>141</number></detail><extent unit="pages"><start>855</start><end>859</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit34"><titleInfo><title>Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck</title></titleInfo><name type="personal"><namePart type="given">CO</namePart><namePart type="family">Mensing</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CH</namePart><namePart type="family">Mensing</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Mensing</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mensing CO, Mensing CH, Mensing H. Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck. Int J Dermatol2008; 47: 960–964.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>960</start><end>964</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Dermatol</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>960</start><end>964</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit35"><titleInfo><title>Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Simpson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Noble</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Simpson D, Noble S. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions. Drugs2005; 65: 827–858.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>827</start><end>858</end></extent></part><relatedItem type="host"><titleInfo><title>Drugs</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>827</start><end>858</end></extent></part></relatedItem></relatedItem><identifier type="istex">B87089D31CCF6EEDCE252176750CAF1DC4B3B16A</identifier><identifier type="ark">ark:/67375/WNG-XJ8Z4VF4-9</identifier><identifier type="DOI">10.1111/j.1365-4632.2011.05449.x</identifier><identifier type="ArticleID">IJD5449</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2012 The International Society of Dermatology</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-15</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XJ8Z4VF4-9/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000943 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000943 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:B87089D31CCF6EEDCE252176750CAF1DC4B3B16A
|texte= A comparative study of clinical characteristics, work‐up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore
}}
| This area was generated with Dilib version V0.6.33. |  |